The comparison of vitamin B1 and placebo effects on the relief of primary dysmenorrheal in university student of Islamic Azad University.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071318458N1

Enrollment

120

Registered

2014-08-29

Start date

2013-07-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Vitamin B1, dose 100 milligram, daily/for 15 day in loteal phase in 2 months. Intervention 2: Placebo, dose 100 miligram, daily for 15 day in loteal phase in 2 mouth.

Treatment - Drugs

Vitamin B1, dose 100 milligram, daily/for 15 day in loteal phase in 2 months

Placebo, dose 100 miligram, daily for 15 day in loteal phase in 2 mouth

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion ceriteria: single women, primary dysmenorrhea? ?Consent for participating in this study Exclusion criteria:any uterine disease or urinary system? irregular mensturation? drug using ralated to dysmenorrhea

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
?Dysmenorrhea. Timepoint: Study begining, First Mounth, Second Mouunth. Method of measurement: Visual Analog Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEnsiyeh Jenabi

Azad University of tuyserkan

enciehjenabi@yahoo.ca+98 814220253

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026